Systemic effects of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=224 Year: 2006
Anabolic steroids in acute and chronic disease Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=163 Year: 2003
Inflammation in COPD: a link to systemic comorbidities Source: Eur Respir Rev 2007; 16: 91-97 Year: 2007
COPD: inflammatory mechanisms and systemic consequences Source: Eur Respir Mon 2013; 59: 13-27 Year: 2013
Leptin, visfatin, insulin resistance, body composition change in chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010
Cachexia in patients with acute COPD exacerbations: relationship to pulmonary function, systemic inflammation and oxidative stress Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008
Osteoporosis and adipose tissue expression of adipokines and osteoprotegerin in severe chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013
Fat metabolism in chronic respiratory disease Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=34 Year: 2003
Cytokines and dietary energy restriction in stable chronic obstructive pulmonary disease patients Source: Eur Respir J 2003 Dec 01;22(6):920-925 Year: 2003
Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS) Year: 2006
Nutritional and metabolic modulation in chronic obstructive pulmonary disease management Source: Eur Respir J 2003; 22: 81S-86S Year: 2003
Hormonal changes and catabolic/anabolic imbalance in chronic obstructive pulmonary disease and their importance for pulmonary cachexia Source: Eur Respir J 2002; 20: Suppl. 38, 202s Year: 2002
Systemic inflammation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD diagnosis Year: 2013
Smoking, systemic inflammation and pulmonary function Source: Eur Respir J 2006; 28: Suppl. 50, 248s Year: 2006
Body composition and plasma levels of inflammatory biomarkers in COPD Source: Eur Respir J 2010; 36: 1027-1033 Year: 2010
Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD diagnosis Year: 2013
The effects of serum leptin on bone metabolism in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009
Oxidant metabolism in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 14S-27S Year: 2003
Different chronic obstructive pulmonary disease phenotypes, systemic inflammation and the risk of falls Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016